• 1. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 2. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 3. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 4. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
• 5. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890

• Solvents and Organic Chemicals Organic Compounds Nucleosides, nucleotides, and analogues Pyrimidine nucleotides Pyrimidine deoxyribonucleotides Pyrimidine deoxyribonucleoside monophosphates

Professional Introduction to OLIGODEOXYCYTIDYLIC ACID D(PC)14 AMMONIUM SALT (CAS No. 29795-73-1)

OLIGODEOXYCYTIDYLIC ACID D(PC)14 AMMONIUM SALT, with the CAS number 29795-73-1, is a specialized chemical compound that has garnered significant attention in the field of biochemical research and pharmaceutical development. This oligonucleotide derivative is particularly notable for its unique structural properties and its potential applications in modulating cellular processes.

The compound is a modified form of deoxyoligonucleotides, featuring a sequence of deoxyribonucleotides with specific modifications. The term D(PC)14 indicates that it consists of a chain of 14 nucleotides, where each nucleotide has been modified at the 2' position with a 3'-phosphorylcholine (PC) group. This modification enhances the stability and bioavailability of the oligonucleotide, making it more suitable for biological applications.

In recent years, there has been growing interest in the development of novel oligonucleotide-based therapeutics due to their ability to interact specifically with biological targets. OLIGODEOXYCYTIDYLIC ACID D(PC)14 AMMONIUM SALT is being explored for its potential in gene therapy, antisense therapy, and as a tool for studying nucleic acid-protein interactions. Its unique chemical structure allows it to exhibit properties that are not typically observed with unmodified oligonucleotides.

One of the most compelling aspects of this compound is its stability in biological environments. The introduction of the 3'-phosphorylcholine group enhances its resistance to degradation by nucleases, which are enzymes that typically break down nucleic acids. This increased stability is crucial for therapeutic applications, as it ensures that the oligonucleotide can reach its target site and exert its intended effect before being metabolized.

Recent studies have demonstrated the potential of OLIGODEOXYCYTIDYLIC ACID D(PC)14 AMMONIUM SALT in modulating gene expression. By binding to specific RNA sequences, this compound can interfere with the transcription or translation processes, thereby influencing cellular functions. For instance, research has shown that it can be used to inhibit the expression of genes involved in inflammation or cancer progression.

The pharmaceutical industry is particularly interested in this compound due to its potential as an antisense drug. Antisense drugs are designed to bind to complementary RNA sequences and block the production of harmful proteins. The ability of OLIGODEOXYCYTIDYLIC ACID D(PC)14 AMMONIUM SALT to resist degradation makes it an ideal candidate for this application.

In addition to its therapeutic potential, this compound has also been used as a research tool in academic laboratories. Its ability to interact specifically with biological targets makes it valuable for studying various cellular processes. For example, researchers have used it to investigate the role of specific RNA sequences in gene regulation and signal transduction pathways.

The synthesis of OLIGODEOXYCYTIDYLIC ACID D(PC)14 AMMONIUM SALT is a complex process that requires precise control over reaction conditions and purification techniques. The introduction of the 3'-phosphorylcholine group necessitates specialized synthetic methodologies that ensure high yield and purity. Despite these challenges, advancements in synthetic chemistry have made it possible to produce this compound on a scale suitable for both research and therapeutic applications.

The safety profile of this compound has also been extensively studied. Preclinical trials have shown that it exhibits low toxicity when administered at therapeutic doses. However, further research is needed to fully understand its long-term effects and potential side effects.

The future prospects for OLIGODEOXYCYTIDYLIC ACID D(PC)14 AMMONIUM SALT are promising, with ongoing research aimed at expanding its applications in medicine and biotechnology. As our understanding of nucleic acid-based therapies continues to grow, this compound is likely to play an increasingly important role in treating a wide range of diseases.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)